Why Puerto Rico?
Puerto Rico is a global leader in biopharmaceutical manufacturing, strategically positioned in the international market. Participants will not only engage in high-level biomanufacturing training but also experience the vibrant, tropical setting that makes Puerto Rico unique.
Located in the heart of the Caribbean, Puerto Rico provides a vibrant tropical setting and a strategic position within global supply chains, making it a critical player in the worldwide biopharmaceutical landscape.
Over the course of this week-long program, participants will be fully engaged in hands-on training, exploring biomanufacturing processes at the Science City of the Puerto Rico Science, Technology, and Research Trust (PRSTRT). This immersive experience will offer students real-world insights into cutting-edge developments in the biopharma sector.
Types of Activities
Hands-On Training
In-depth lab exercises focusing on key biomanufacturing processes such as cell culture, and protein purification, providing real-world industry skills.
Types of Activities
Industry Visits
Participants will tour top biopharma companies, including Amgen, Lilly, Cytoimmune, AbbVie, and Bristol Myers, gaining direct exposure to cutting-edge manufacturing environments.
Types of Activities
Professional Development
Tailored workshops on resume building, networking, and career preparation, focused on enhancing opportunities for early-career STEM students.
Types of Activities
Mentorship & Networking
Engage with experienced industry professionals and career advisors to build confidence and connections for future opportunities.
What’s Included?
This program is entirely free for all participants! Travel, housing, meals, and all program expenses are fully covered. Additionally, participants will receive a $1,000 stipend upon completing the program.
Dates & Deadlines
Deadline: February 5, 2026
Information about the 2026 NIIMBL eXperience is available at: www.niimbl.org/workforce/niimbl-experience/
Thank You to NIIMBL
This project was developed with an award from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and financial assistance from the U.S. Department of Commerce, National Institute of Standards and Technology (70NANB21H086).